NCATS SBIR Phase II
Backs small businesses scaling proven translational findings into applied solutions and early market readiness.
The National Center for Advancing Translational Sciences (NCATS) administers SBIR Phase II grants (R44) to support expanded research, development, and early commercialization activities for small US businesses that have demonstrated feasibility in a Phase I award. NCATS's four priority topic areas — preclinical drug discovery and development, biomedical and health research informatics, clinical an…
Expanded R&D and commercialization for small businesses in preclinical drug discovery, biomedical informatics, clinical and dissemination research, and rare disease applications.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline